Teva Pharmaceutical Industries forward PE TEVA

Share price divided by analysts' consensus earnings for the next twelve months, since 1995.

Today, Oct 23, 2026: 14.1×
10-year median: 5.4×
Against its 10-year history: 93rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 2.8× to 17.6×
Peer median: 28.7×

Teva Pharmaceutical Industries' forward PE is 14.1× as of Oct 23, 2026.

That is above its ten-year median of 5.4×, higher than on 93% of days in the last ten years.

Over that time it ranged from 2.8× in Aug 2019 to 17.6× in Feb 2026.

The median for 10 healthcare stocks of a similar size is 28.7×.

Forward PE over time

median 5.4×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	14.1×	12.5×	17.6×
2025	17.1×	5.6×	17.1×
2024	9.3×	4.5×	9.3×
2023	4.2×	3.0×	4.7×
2022	3.8×	2.8×	4.6×
2021	3.2×	3.2×	5.1×
2020	3.9×	3.1×	5.7×
2019	4.3×	2.8×	8.6×
2018	6.9×	6.6×	10.8×
2017	7.0×	4.1×	9.1×
2016	8.1×	8.1×	13.2×
2015	13.6×	11.6×	14.5×
2014	11.8×	8.1×	12.0×
2013	8.1×	7.4×	8.4×
2012	7.6×	7.6×	8.7×
2011	7.4×	6.5×	11.9×
2010	11.3×	10.7×	15.3×
2009	13.9×	12.9×	15.4×
2008	13.9×	13.7×	19.9×
2007	19.0×	15.3×	19.0×

Against its peers

Companies in Healthcare nearest Teva Pharmaceutical Industries' size, closest first, today.

Company	Forward PE
TEVATeva Pharmaceutical Industries	14.1×
IQVIQVIA	20.5×
MDLNMedline	23.2×
WATWaters	29.2×
IDXXIDEXX Laboratories	35.9×
AAgilent Technologies	26.4×
ONCBeOne Medicines	48.1×
HUMHumana	33.7×
EWEdwards Lifesciences	28.3×
ILMNIllumina	47.2×
BDXBecton, Dickinson and	15.1×
Peer median	28.7×

Where Teva Pharmaceutical Industries ranks

#11of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Teva Pharmaceutical Industries

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.